Neuronetics Stock Widgets and Gadgets
| STIM Stock | USD 0.61 0.08 11.59% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- STIM Neuronetics
- Latest CORRECTIONNeuronetics Reports Record Third Quarter 2024 Financial and Operating Results
- STIM 0.61 -0.08
- Low 0.58
- High 0.69
- Volume 1.3 M
- Alpha -0.3
- Beta 2.94
- Return On Equity -1.0
- Return On Asset -0.17
- Profit Margin (0.45) %
- Operating Margin (0.52) %
- Current Valuation 52.63 M
- Shares Outstanding 30.3 M
- Shares Owned By Insiders 11.00 %
- Shares Owned By Institutions 54.01 %
- Number Of Shares Shorted 735.04 K
- Price To Book 1.72 X
- Price To Sales 0.29 X
- Revenue 71.35 M
- Gross Profit 49.72 M
- EBITDA (28.55 M)
- Net Income (30.19 M)
- Cash And Equivalents 73.7 M
- Cash Per Share 2.71 X
- Total Debt 62.47 M
- Debt To Equity 0.63 %
- Current Ratio 4.02 X
- Book Value Per Share 0.64 X
- Cash Flow From Operations (32.04 M)
- Short Ratio 2.00 X
- Earnings Per Share (1.10) X
- Target Price 3.33
- Number Of Employees 203
- Beta 2.22
- Market Capitalization 20.91 M
- Total Asset 115.83 M
- Retained Earnings (376.08 M)
- Working Capital 73.98 M
- Net Asset 115.83 M
- Accumulation Distribution 211786.0
- Daily Balance Of Power (0.73)
- Rate Of Daily Change 0.88
- Day Median Price 0.64
- Day Typical Price 0.63
- Price Action Indicator (0.07)
- Period Momentum Indicator (0.08)
- Relative Strength Index 62.31
Market Snapshot Widget Example
DAX Index Germany | 19,003 0.16 | |
Taiwan Weighted Taiwan | 22,860 0.53 | |
PSI 20 Stock Portugal | 6,295 0.6 | |
CROBEX Croatia | 3,115 0.55 | |
Budapest SE Hungary | 77,124 0.20 | |
IDX 30 Jakarta Indonesia | 454.02 0.27 | |
ISEQ 20 Price Ireland | 1,624 1.14 | |
NYSE Comp USA | 19,845 0.04 | |
Tel Aviv 35 Israel | 2,303 0.23 | |
Coreshares Index Tracker South Afric | 1,093 0.91 | |
IPC MEXICO Mexico | 50,848 0.49 | |
KL Technology Malaysia | 60.05 0.52 | |
IBEX 35 Index Spain | 11,377 0.05 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,461 1.16 | |
SPASX Dividend Opportunities Australia | 1,660 0.49 | |
HNX 30 Vietnam | 486.55 0.21 | |
Bucharest BET-NG Romania | 1,252 1.00 | |
AMS Small Cap Netherlands | 1,174 0.72 | |
Oslo Exchange Mutual Norway | 1,365 0.61 | |
BEL Small Belgium | 8,347 0.66 | |
Basic Materials Brazil | 5,619 0.14 | |
Swiss Leader Price Switzerland | 1,922 0.25 | |
Fondo Mutuo ETF Chile | 1,358 0.29 | |
Athens General Comp Greece | 1,420 0.8 | |
Stock Exchange Of Thailand | 1,451 0.44 | |
PX Prague Stock Czech Repub | 1,668 0.1 | |
THE PHILIPPINE STOCK Philippines | 6,714 1.41 | |
WIG 30 Poland | 2,833 0.98 | |
BIST Electricity Turkey | 477.65 0.05 |
Investing Ideas
In addition to having Neuronetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Neuronetics
Compare Neuronetics To Peers
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Revenue Per Share 2.453 | Quarterly Revenue Growth (0.07) | Return On Assets (0.17) | Return On Equity (1.00) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.